trending Market Intelligence /marketintelligence/en/news-insights/trending/QEN4jVOU06-4LZ4tCM_e_w2 content esgSubNav
In This List

Biopharmaceutical company Exelixis repays term loan ahead of time

Blog

Insight Weekly: US bank stress tests; cracks in housing market; summer energy supply risks

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches


Biopharmaceutical company Exelixis repays term loan ahead of time

Exelixis Inc. repaid its outstanding term loan with the Silicon Valley Bank.

The loan, initiated in 2010, was due for repayment May 31.

The repayment included $80 million in principal and about $60,000 in outstanding interest. The biopharmaceutical company also plans to extinguish more debt later this year by retiring a series of convertible secured notes.

The notes, issued to entities associated with Deerfield Management Company LP, are due July 1, 2018.